Glucocorticoids are steroid hormones produced by the adrenal glands that touch virtually every organ system in the body, from how you burn fuel to how your immune system responds to infection to how your bones maintain their density. Cortisol, the primary glucocorticoid in humans, is often reduced to a “stress hormone” in popular culture, but that label barely scratches the surface. These hormones regulate metabolism, blood pressure, inflammation, brain function, and even fetal development, and the consequences of having too much or too little can be severe and wide-ranging.
How the Body Produces and Controls Cortisol
Cortisol production is governed by a signaling chain that starts in the brain and ends in the adrenal glands, sitting atop your kidneys. When the brain detects a need for cortisol, whether from physical stress, low blood sugar, or psychological threat, a region of the hypothalamus called the paraventricular nucleus releases corticotrophin-releasing hormone (CRH). CRH travels to the pituitary gland, which responds by secreting adrenocorticotropic hormone (ACTH) into the bloodstream. ACTH then reaches the adrenal cortex, triggering cortisol release.1Europe PMC. Regulation of the Hypothalamic-Pituitary-Adrenocortical Stress Response
This system has a built-in brake. Once cortisol levels rise high enough, the hormone feeds back on the hypothalamus and pituitary to suppress further CRH and ACTH release, preventing runaway production. Cortisol can also act quickly on neurons in the hypothalamus through receptors on cell membranes, providing a rapid shut-off mechanism in addition to the slower genomic feedback loop.1Europe PMC. Regulation of the Hypothalamic-Pituitary-Adrenocortical Stress Response Limbic brain structures like the hippocampus also participate in damping down the stress response, which is one reason chronic stress and hippocampal damage can leave cortisol regulation impaired.
The Daily Rhythm of Cortisol
Cortisol is not released at a steady rate throughout the day. It follows a pronounced circadian pattern, peaking in the early morning hours and hitting its lowest point around midnight. One particularly well-studied feature is the cortisol awakening response, a sharp spike that occurs within the first 30 to 45 minutes after waking. Research has shown this spike has a robust circadian rhythm of its own, peaking at a circadian phase corresponding to roughly 3:40 to 3:45 a.m. and largely absent during afternoon circadian phases.2PubMed Central. The circadian system modulates the cortisol awakening response in humans
The brain’s master clock, located in the suprachiasmatic nucleus, orchestrates this rhythm through both the standard hormonal cascade and a separate nerve pathway running directly to the adrenal gland. This second route, carried through sympathetic nerves, modulates how sensitive the adrenal gland is to ACTH and appears to be influenced by light exposure.3Endocrine Reviews. The Cortisol Awakening Response: Regulation and Functional Significance For shift workers who wake up at unconventional times, this matters: the cortisol awakening response can be blunted when waking occurs at a circadian phase where the body does not expect it, potentially leaving those workers less prepared to handle stressors after waking.2PubMed Central. The circadian system modulates the cortisol awakening response in humans
What Glucocorticoids Actually Do Inside Cells
Once cortisol reaches a target cell, it works through two broad pathways. The “genomic” route involves cortisol binding to glucocorticoid receptors in the cell’s interior, which then migrate to the nucleus and attach to DNA, switching specific genes on or off. This is relatively slow, taking hours to produce noticeable effects. The “non-genomic” route is much faster, operating within minutes through receptors on cell membranes that activate signaling cascades involving enzymes and second messengers like calcium ions.4PubMed Central. Genomic and non-genomic effects of glucocorticoids: implications for breast cancer Both pathways are at work throughout the body, and the balance between them helps explain why glucocorticoids can have such varied effects depending on the tissue and the time scale involved.5PubMed Central. Effects of glucocorticoids on leukocytes: Genomic and non-genomic mechanisms
Tissue-Level Volume Control
One of the less intuitive aspects of glucocorticoid biology is that individual tissues can dial their own cortisol exposure up or down independently of what the adrenal glands are putting out. They do this using a pair of enzymes called 11-beta-hydroxysteroid dehydrogenases. One version, called type 1, converts inactive cortisone back into active cortisol, effectively amplifying the glucocorticoid signal within that tissue. The other version, type 2, does the opposite, inactivating cortisol into cortisone.6PubMed. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase
This arrangement is especially important in the kidneys, where the type 2 enzyme protects a receptor called the mineralocorticoid receptor from being overwhelmed by cortisol. Cortisol circulates in the blood at much higher concentrations than aldosterone, the hormone that normally activates mineralocorticoid receptors to regulate sodium and blood pressure. Without the type 2 enzyme shielding those receptors, cortisol would constantly mimic aldosterone, causing salt retention and high blood pressure.7PubMed Central. 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action
In other tissues, the type 1 enzyme generates cortisol locally. In skeletal muscle, for instance, activity of this enzyme has been linked to the development of metabolic problems, suggesting it plays a role in conditions like metabolic syndrome by amplifying glucocorticoid effects in muscle tissue specifically.8PubMed. The cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in the pathogenesis of the metabolic syndrome The ability of peripheral tissues to independently regulate their own cortisol exposure is now recognized as a significant factor in human disease.6PubMed. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase
Metabolism, Immunity, and Blood Pressure
Glucocorticoids are deeply woven into how your body manages energy. They promote the breakdown of stored glycogen into glucose, stimulate the production of new glucose from non-carbohydrate sources, and encourage fat redistribution. At normal physiological levels, these effects keep fuel available when it is needed. But when glucocorticoid levels stay chronically elevated, the result is whole-body insulin resistance, obesity, and cardiovascular disease.9Europe PMC. Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism
On the immune side, glucocorticoids are the body’s primary endogenous brake on inflammation. A key mechanism is their interference with NF-kappa-B, a transcription factor that drives the expression of pro-inflammatory genes. By disrupting NF-kappa-B’s ability to interact with the cell’s gene-reading machinery, glucocorticoids suppress the production of inflammatory proteins at the source.10PubMed. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell This is exactly the property exploited by synthetic glucocorticoids used as medications for asthma, autoimmune conditions, and organ transplant rejection.
Cortisol also affects blood pressure by amplifying the responsiveness of blood vessels to catecholamines like norepinephrine. Excess cortisol increases how strongly arteries contract in response to these signals, raising vascular resistance and blood pressure.11PubMed. Glucocorticoids and vascular reactivity12PubMed Central. Cardiovascular Consequences of Cortisol Excess – Section: Sympathetic nervous system
Bones Under Siege
The skeletal system is particularly vulnerable to prolonged glucocorticoid excess. Glucocorticoids disrupt the normal balance between bone-building and bone-breakdown in two directions simultaneously. They promote the formation of osteoclasts, the cells that dissolve bone, and extend those cells’ lifespan. At the same time, they inhibit the formation of osteoblasts, the bone-building cells, and accelerate their death. The combined result is accelerated bone loss.13PubMed Central. The molecular etiology and treatment of glucocorticoid-induced osteoporosis Glucocorticoid-induced osteoporosis is one of the most common forms of secondary osteoporosis, and it is a well-known complication for people on long-term steroid medications for conditions like rheumatoid arthritis or inflammatory bowel disease.
Preparing the Fetal Lungs to Breathe
One of the more remarkable roles of glucocorticoids is in fetal development, specifically in getting the lungs ready for life outside the womb. During gestation, glucocorticoids stimulate the production of surfactant, a slippery coating that lines the air sacs and prevents them from collapsing with each breath. In animal studies, cortisol treatment of fetal rabbits nearly doubled the amount of the key surfactant component (phospholipid) in the lungs compared to untreated controls, bringing the lung composition to a level matching a fetus at a more advanced gestational age.14PubMed. Studies on pulmonary surfactant. Effects of cortisol administration to fetal rabbits on lung phospholipid content, composition and biosynthesis
Beyond surfactant, glucocorticoids also promote cell maturation and differentiation in the developing lung, stimulate antioxidant enzymes, and influence fluid metabolism within the lung tissue.15PubMed. Glucocorticoids and lung development in the fetus and preterm infant This is the basis for administering synthetic corticosteroids to pregnant women at risk of preterm delivery, one of the most successful interventions in neonatal medicine. The treatment accelerates lung maturation enough to dramatically reduce the risk of respiratory distress syndrome in premature infants.
When There Is Too Much Cortisol
Cushing syndrome is the clinical picture that results from chronic cortisol excess, whether from a pituitary tumor overproducing ACTH, an adrenal tumor secreting cortisol autonomously, or prolonged use of synthetic glucocorticoid medications. The syndrome is associated with cardiovascular and metabolic disorders, musculoskeletal changes, and cognitive and mood impairment, all of which reduce quality of life and life expectancy.16The Journal of Clinical Endocrinology & Metabolism. Long-Term Consequences of Cushing Syndrome: A Systematic Literature Review – Section: Results Mortality is increased from causes including pulmonary blood clots, infections, heart attacks, and strokes.17Nature Reviews Disease Primers. Glucocorticoid Hormones: Functions, Regulation & Imbalances
Many of the features of Cushing syndrome map directly onto the metabolic and skeletal effects described above, just pushed to a pathological extreme: central obesity, thinning skin, easy bruising, high blood sugar, high blood pressure, bone loss, and muscle weakness. Mood disturbances are common too, ranging from depression and anxiety to psychosis in severe cases. Even after the underlying cause is treated and cortisol levels normalize, some of these effects, particularly cardiovascular risk and bone fragility, can linger for years.
When There Is Too Little
The opposite condition, primary adrenal insufficiency or Addison’s disease, occurs when the adrenal cortex fails and stops producing adequate cortisol and aldosterone. In its acute form, adrenal crisis can cause dangerously low blood pressure, fever, and low blood sugar. The chronic version develops more slowly, with fatigue, appetite loss, weight loss, diarrhea, and joint and back pain.18PubMed. Addison’s disease
A distinctive hallmark of Addison’s disease is darkening of the skin, especially in sun-exposed areas, palmar creases, areas subject to friction, and the gums and inner lip. This hyperpigmentation happens because the pituitary gland, no longer suppressed by cortisol feedback, dramatically ramps up ACTH production. ACTH is made from the same precursor molecule as melanocyte-stimulating hormone, so the excess ACTH drives melanin production in the skin.
While autoimmune destruction of the adrenal glands remains the most common cause in developed countries, other triggers include infections, cancers, and increasingly, medications. Certain anticoagulants can cause adrenal hemorrhage, and some newer cancer immunotherapy drugs can trigger adrenal failure as an immune-related side effect.19PubMed. An Update on Addison’s Disease
Why Some People Respond Differently to Stress Hormones
Not everyone’s cells respond to cortisol equally, and a key reason is genetic variation in a protein called FKBP5. This protein acts as a gatekeeper at the glucocorticoid receptor: when FKBP5 is bound to the receptor complex, cortisol binds with lower affinity, and the receptor moves to the cell nucleus less efficiently.20PubMed. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders In other words, more FKBP5 means a cell is less responsive to cortisol.
People carry different versions of the FKBP5 gene. Certain variants lead to stronger upregulation of FKBP5 every time the glucocorticoid receptor is activated, creating a feedback loop where each cortisol surge makes the cell slightly more resistant to the next one. Carriers of these variants show greater glucocorticoid resistance and less efficient negative feedback on the stress hormone axis.20PubMed. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders Research using mice engineered to carry human FKBP5 variants has confirmed that even a single genetic difference in this gene can alter glucocorticoid responsiveness in brain cells, with the “risk” allele associated with greater FKBP5 induction and reduced cortisol sensitivity compared to the “resilience” allele.21PubMed Central. FKBP5 polymorphisms induce differential glucocorticoid responsiveness in primary CNS cells – First insights from novel humanized mice
In the hippocampus specifically, mineralocorticoid receptors appear to set the baseline level of FKBP5, which in turn determines how sensitive glucocorticoid receptors are to cortisol. This creates a layered system for fine-tuning how the brain responds to stress.22PubMed Central. Mineralocorticoid receptors dampen glucocorticoid receptor sensitivity to stress via regulation of FKBP5 FKBP5 variants have been linked to susceptibility to depression, post-traumatic stress disorder, and other stress-related psychiatric conditions, making this protein a focus of ongoing drug development efforts.
Measuring Cortisol Beyond the Blood Draw
Cortisol measurement is central to diagnosing both Cushing syndrome and adrenal insufficiency, but the standard options, blood draws and saliva samples, only capture a snapshot of what cortisol is doing right now. Because cortisol fluctuates so dramatically over the course of a day and in response to stress, a single sample can be misleading.
Hair cortisol analysis has emerged as a way to measure average cortisol exposure over weeks to months. As hair grows, cortisol is incorporated into the shaft, creating a timeline of hormone levels that can be read by cutting and analyzing segments. Systematic review of the evidence has identified hair cortisol as the most reliable available biomarker for chronic stress.23PubMed Central. Physiological biomarkers of chronic stress: A systematic review – Section: Hair cortisol It has shown promise for characterizing chronic stress as a risk factor for disease progression and for evaluating whether stress-reduction interventions are working.24PubMed Central. Hair Cortisol Analysis: A Promising Biomarker of HPA Activation in Older Adults
An interesting wrinkle in hair cortisol research is sex differences. In a study of university students during exam periods, male students had average hair cortisol concentrations roughly double those of female students.25PubMed Central. A Dual Biomarker Approach to Stress: Hair and Salivary Cortisol Measurement in Students via LC-MS/MS Whether this reflects differences in cortisol production, hair biology, or some combination is still being worked out. Hair cortisol has limits too: it cannot distinguish between cortisol produced by the adrenal glands and cortisol generated locally in the scalp by the type 1 enzyme discussed earlier, and factors like hair treatment, color, and washing frequency can affect readings.
Glucocorticoids in Critical Illness
When patients develop severe sepsis, the body’s normal cortisol response can become insufficient relative to the extreme demands of overwhelming infection. In that setting, administering low-dose synthetic glucocorticoids like hydrocortisone can help restore cardiovascular stability, reduce systemic inflammation, and improve organ function. Evidence-based guidance suggests initiating corticosteroids in sepsis patients who require high doses of vasopressor medications to maintain blood pressure, typically at a hydrocortisone dose of about 200 milligrams per day for five to seven days.26PubMed Central. Corticosteroids for severe sepsis: an evidence-based guide for physicians
This use of glucocorticoids in critical care is conceptually distinct from using them to suppress inflammation in chronic disease. In sepsis, the goal is not immunosuppression per se but rather replacement of a physiological hormone response that has become inadequate. The timing and dose matter enormously: too much can worsen immune suppression in an already-infected patient, while too little may not provide meaningful benefit.
The Gut Microbiome as a Cortisol Regulator
A newer and still developing area of research involves the role of gut bacteria in cortisol metabolism. Recent work has found that gut microbiota can actually degrade cortisol, and this ability varies between individuals. In mice, transplanting gut bacteria with a low capacity to break down cortisol made the animals more prone to depressive-like behavior. One bacterial strain isolated from human feces was shown to convert cortisol into an androgen using a specific enzyme, and introducing this enzyme into mice protected them against depressive-like behavior.27PubMed Central. Gut Bacteria Improve Depressive Symptoms by Degrading Cortisol into Androgen
Separately, comparisons between mice raised in a sterile environment and those with normal gut bacteria have shown that the microbiome influences how peripheral tissues handle glucocorticoids during chronic stress, affecting the expression of the type 1 enzyme that converts cortisone to cortisol in the colon and modulating genes involved in glucocorticoid receptor sensitivity in the pituitary and adrenal glands.28PubMed. Microbiota affects the expression of genes involved in HPA axis regulation and local metabolism of glucocorticoids in chronic psychosocial stress These findings are still largely preclinical, and translating them to human therapies remains a long way off. But they suggest that the trillions of bacteria living in your intestines are not merely bystanders in the cortisol story.
How the Glucocorticoid System Evolved
The glucocorticoid receptor and its close relative the mineralocorticoid receptor both descend from a single ancestral corticoid receptor. The earliest known versions of this receptor appear in lamprey and hagfish, jawless fish that branched off the vertebrate family tree hundreds of millions of years ago. The lamprey’s ancestral receptor responds to both cortisol and aldosterone-like signals, essentially handling the work of both modern receptor types in one protein.29PubMed. Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors
Distinct glucocorticoid and mineralocorticoid receptors first appear in cartilaginous fish like sharks and skates, likely as a result of a whole-genome duplication event early in the evolution of jawed vertebrates.30PubMed. Evolution of the Mineralocorticoid Receptor31PubMed. Evolution of the corticosteroid receptor signalling pathway in fish After duplication, the two receptors gradually specialized: the mineralocorticoid receptor retained high sensitivity to cortisol and eventually became the primary receptor for aldosterone in land-dwelling vertebrates, while the glucocorticoid receptor developed lower cortisol affinity but broader tissue expression. This split allowed vertebrates to use the same basic hormone, cortisol, for two distinct physiological purposes: moment-to-moment salt and water balance through the mineralocorticoid receptor, and broader metabolic and immune regulation through the glucocorticoid receptor. That dual-use design is also why the type 2 enzyme described earlier is so critical for keeping cortisol from overwhelming mineralocorticoid receptors in the kidney.